NCT00964548View on ClinicalTrials.gov

Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Cerebral Vasospasm After Subarachnoid Hemorrhage
Interventions
DRUG

Dantrolene

1.25 mg/kg IV once over 60 min

DRUG

Dantrolene

2.5 mg/kg IV once over 60 min

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

01655

UMASS Memorial Medical Center/UMASS Medical School, Worcester

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

University of Massachusetts, Worcester

OTHER

NCT00964548 - Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage | Biotech Hunter | Biotech Hunter